Adherence and persistence among multiple sclerosis patients after one immunomodulatory therapy failure: Retrospective claims analysis

被引：0
|
作者：
Rachel Halpern
Sonalee Agarwal
Leigh Borton
Kathy Oneacre
Maria V. Lopez-Bresnahan
机构：
[1] OptumInsight,Health Economics and Outcomes Research
[2] Biogen Idec,Health Economics and Outcomes Research
[3] OptumInsight,undefined
[4] Medical and Scientific Affairs,undefined
来源：
Advances in Therapy | 2011年 / 28卷
关键词：
drug therapy; medication adherence; medication persistence; multiple sclerosis; retrospective studies;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：761 / 775
页数：14
相关论文
共 50 条
  • [41] Adherence to injection therapy in multiple sclerosis: Patients survey
    Hadjimichael, O
    Vollmer, TL
    NEUROLOGY, 1999, 52 (06) : A549 - A549
  • [42] Therapy adherence to immunomodulator treatment in patients with multiple sclerosis
    Lopez-Mendez, Pino
    Rio, Jordi
    Perez-Ricart, Ariadna
    Tintore, Mar
    Sastre-Garriga, Jaunne
    Cardona-Pascual, Ignacio
    Rosa Gomez-Domingo, M.
    Montalban, Xavier
    REVISTA DE NEUROLOGIA, 2013, 56 (01) : 8 - 12
  • [43] Adherence to Therapy in Patients with Multiple Sclerosis-Review
    Koltuniuk, Aleksandra
    Chojdak-Lukasiewicz, Justyna
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (04)
  • [44] Adherence to thyroid hormone replacement therapy: a retrospective, claims database analysis
    Hepp, Zsolt
    Wyne, Kathleen
    Manthena, Shivaji R.
    Wang, Siting
    Gossain, Ved
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (09) : 1673 - 1678
  • [45] DIFFERENT TREATMENTS AND ADHERENCE TO THERAPY IN MULTIPLE SCLEROSIS PATIENTS
    Alteri, Lorenzo
    Sollini, Maria Laura
    Spicchiale, Claudia Fede
    Ambrosi, Virgilio Michael
    Agro, Enrico Finazzi
    Orecchia, Luca
    Varca, Simone
    NEUROUROLOGY AND URODYNAMICS, 2021, 40 : S102 - S103
  • [46] Retrospective Claims Analysis of Treatment Patterns, Relapse, Utilization, and Cost Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
    Freeman, Leorah
    Kee, Arianna
    Tian, Marc
    Mehta, Rina
    DRUGS-REAL WORLD OUTCOMES, 2021, 8 (04) : 497 - 508
  • [47] Retrospective Claims Analysis of Treatment Patterns, Relapse, Utilization, and Cost Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
    Leorah Freeman
    Arianna Kee
    Marc Tian
    Rina Mehta
    Drugs - Real World Outcomes, 2021, 8 : 497 - 508
  • [48] A retrospective claims analysis: Compliance and discontinuation rates among Canadian patients with multiple sclerosis treated with disease-modifying therapies
    Duquette, Pierre
    Yeung, Michael
    Mouallif, Soukaina
    Nakhaipour, Hamid Reza
    Haddad, Paola
    Schecter, Robyn
    PLOS ONE, 2019, 14 (01):
  • [49] Costs associated with failure to respond to treatment among patients with rheumatoid arthritis initiating TNFi therapy: a retrospective claims analysis
    Grabner, Michael
    Boytsov, Natalie N.
    Huang, Qing
    Zhang, Xiang
    Yan, Tingjian
    Curtis, Jeffrey R.
    ARTHRITIS RESEARCH & THERAPY, 2017, 19
  • [50] Costs associated with failure to respond to treatment among patients with rheumatoid arthritis initiating TNFi therapy: a retrospective claims analysis
    Michael Grabner
    Natalie N. Boytsov
    Qing Huang
    Xiang Zhang
    Tingjian Yan
    Jeffrey R. Curtis
    Arthritis Research & Therapy, 19
12345